Synthetic Short Cryptic Antimicrobial Peptides as Templates for the Development of Novel Biotherapeutics Against WHO Priority Pathogen

Background The emergence of multidrug-resistant pathogens through excessive and indiscriminate use of antibiotics, together with the lack of highly efficient treatment options for bacterial infections, has raised the development of novel antimicrobial agents to top priority. In this context, cryptic...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of peptide research and therapeutics Vol. 30; no. 5; p. 57
Main Authors Lata, Manjul, Telang, Vrushti, Gupta, Pooja, Pant, Garima, Kalyan, Mitra, Arockiaraj, Jesu, Pasupuleti, Mukesh
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 12.09.2024
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1573-3904
1573-3149
1573-3904
DOI10.1007/s10989-024-10632-8

Cover

Loading…
Abstract Background The emergence of multidrug-resistant pathogens through excessive and indiscriminate use of antibiotics, together with the lack of highly efficient treatment options for bacterial infections, has raised the development of novel antimicrobial agents to top priority. In this context, cryptic host defense peptides (cHDPs) are being explored as a novel class of antimicrobial agents. In this study, short peptides were designed from the long nonantibacterial protein ToAP2 and analysed for their positive net charge, hydrophobicity, hydrophobic moment, hydrophobic and hydrophilic planes. Methods From the designed fragments, five 15 amino acid fragments were synthesised by solid-phase peptide synthesis (SPPS) and analysed for antimicrobial activity against ESKAPE pathogens. All the peptides were subject to cytotoxicity, mode of action, structure and function studies to find the best template for further optimisation. Results Among them, two peptides, FKL15 and SKL15, showed better efficiency in killing P. aeruginosa under physiological salt and plasma conditions with no cytotoxicity issues. Further, the peptides destroyed the bacterial membranes and adopted a random coil structure in the presence of the bacteria. Conclusions The data indicates that FKL15 and SKL15 are promising antimicrobial peptides against antibiotic-resistant bacteria with great potential to develop as drugs with high economic value.
AbstractList BackgroundThe emergence of multidrug-resistant pathogens through excessive and indiscriminate use of antibiotics, together with the lack of highly efficient treatment options for bacterial infections, has raised the development of novel antimicrobial agents to top priority. In this context, cryptic host defense peptides (cHDPs) are being explored as a novel class of antimicrobial agents. In this study, short peptides were designed from the long nonantibacterial protein ToAP2 and analysed for their positive net charge, hydrophobicity, hydrophobic moment, hydrophobic and hydrophilic planes.MethodsFrom the designed fragments, five 15 amino acid fragments were synthesised by solid-phase peptide synthesis (SPPS) and analysed for antimicrobial activity against ESKAPE pathogens. All the peptides were subject to cytotoxicity, mode of action, structure and function studies to find the best template for further optimisation.ResultsAmong them, two peptides, FKL15 and SKL15, showed better efficiency in killing P. aeruginosa under physiological salt and plasma conditions with no cytotoxicity issues. Further, the peptides destroyed the bacterial membranes and adopted a random coil structure in the presence of the bacteria.ConclusionsThe data indicates that FKL15 and SKL15 are promising antimicrobial peptides against antibiotic-resistant bacteria with great potential to develop as drugs with high economic value.
Background The emergence of multidrug-resistant pathogens through excessive and indiscriminate use of antibiotics, together with the lack of highly efficient treatment options for bacterial infections, has raised the development of novel antimicrobial agents to top priority. In this context, cryptic host defense peptides (cHDPs) are being explored as a novel class of antimicrobial agents. In this study, short peptides were designed from the long nonantibacterial protein ToAP2 and analysed for their positive net charge, hydrophobicity, hydrophobic moment, hydrophobic and hydrophilic planes. Methods From the designed fragments, five 15 amino acid fragments were synthesised by solid-phase peptide synthesis (SPPS) and analysed for antimicrobial activity against ESKAPE pathogens. All the peptides were subject to cytotoxicity, mode of action, structure and function studies to find the best template for further optimisation. Results Among them, two peptides, FKL15 and SKL15, showed better efficiency in killing P. aeruginosa under physiological salt and plasma conditions with no cytotoxicity issues. Further, the peptides destroyed the bacterial membranes and adopted a random coil structure in the presence of the bacteria. Conclusions The data indicates that FKL15 and SKL15 are promising antimicrobial peptides against antibiotic-resistant bacteria with great potential to develop as drugs with high economic value.
ArticleNumber 57
Author Pasupuleti, Mukesh
Telang, Vrushti
Lata, Manjul
Pant, Garima
Kalyan, Mitra
Gupta, Pooja
Arockiaraj, Jesu
Author_xml – sequence: 1
  givenname: Manjul
  orcidid: 0000-0002-4413-2641
  surname: Lata
  fullname: Lata, Manjul
  email: manjul3dxyz@gmail.com
  organization: Division of Molecular Microbiology & Immunology, CSIR-Central Drug Research Institute, AcSIR: Academy of Scientific and Innovative Research (AcSIR)
– sequence: 2
  givenname: Vrushti
  orcidid: 0000-0003-3772-9711
  surname: Telang
  fullname: Telang, Vrushti
  organization: Division of Molecular Microbiology & Immunology, CSIR-Central Drug Research Institute
– sequence: 3
  givenname: Pooja
  orcidid: 0000-0002-9618-1998
  surname: Gupta
  fullname: Gupta, Pooja
  organization: Division of Molecular Microbiology & Immunology, CSIR-Central Drug Research Institute
– sequence: 4
  givenname: Garima
  surname: Pant
  fullname: Pant, Garima
  organization: Electron Microscopy Unit, CSIR-Central Drug Research Institute
– sequence: 5
  givenname: Mitra
  surname: Kalyan
  fullname: Kalyan, Mitra
  organization: Electron Microscopy Unit, CSIR-Central Drug Research Institute
– sequence: 6
  givenname: Jesu
  orcidid: 0000-0002-0240-7141
  surname: Arockiaraj
  fullname: Arockiaraj, Jesu
  organization: Department of Biotechnology, College of Science and Humanities, SRM Institute of Science and Technology
– sequence: 7
  givenname: Mukesh
  orcidid: 0000-0001-6337-6257
  surname: Pasupuleti
  fullname: Pasupuleti, Mukesh
  email: mukesh_p78@yahoo.com, mukesh.p@cdri.res.in
  organization: Division of Molecular Microbiology & Immunology, CSIR-Central Drug Research Institute, AcSIR: Academy of Scientific and Innovative Research (AcSIR)
BookMark eNp9UMtOwzAQtBBIPH-AkyXOgbWTOPGxlKeEoFKLOFpOsmmNWjvYLlJ_gO_GUCQ4cdqd3ZlZ7RySXessEnLK4JwBVBeBgaxlBrzIGIicZ_UOOWBllWe5hGL3T79PDkN4BSh5xeCAfEw3Ni4wmpZOF85HOvab4QuNbDQr03rXGL2kE0zDDgPVgc5wNSx1TKB3niYxvcJ3XLphhTZS19NHlyC9NC7tvB5wnfwCHc21sSHSl7snOvHGeRM3dKLjws3RHpO9Xi8DnvzUI_J8cz0b32UPT7f349FD1vIKYsbLmhXY9pWoW-wk70TNJPCm7LAt2ko0ogNscikraCQWtSirotOs5JxBC73Oj8jZ1nfw7m2NIapXt_Y2nVQ5g1wIAbJILL5lpfdD8NirwZuV9hvFQH3lrbZ5q5S3-s5b1UmUb0Uhke0c_a_1P6pP-VyGzQ
Cites_doi 10.3389/fmicb.2022.862834
10.1007/s10989-016-9553-5
10.1016/j.ijheh.2022.114006
10.1093/jac/dkac014
10.1016/j.bbagen.2009.03.029
10.1021/acs.bioconjchem.2c00115
10.1002/psc.2894
10.1016/j.bmcl.2020.127746
10.3389/fmolb.2022.887763
10.1080/08977190701344120
10.1007/s12602-022-09915-7
10.1039/D2MD00048B
10.1002/psc.3306
10.1007/s10989-018-9793-7
10.3389/fchem.2021.691532
10.3389/fmicb.2021.773076
10.2174/1381612824666180327165012
10.2174/1568026620666200325112425
10.1111/jfbc.13598
10.1371/journal.ppat.1000857
10.1016/j.addr.2022.114378
10.3389/fmicb.2022.817228
10.1002/psc.3446
10.3389/fbioe.2020.00162
10.1177/1091581820977846
10.2217/fmb-2021-0257
10.3389/fmicb.2016.01844
10.1038/s41598-020-66995-7
10.1016/j.bbamem.2022.183955
10.1021/acsinfecdis.6b00045
10.3389/fmicb.2021.678330
10.1016/j.micpath.2021.105301
10.1007/s12275-024-00113-4
10.1016/j.peptides.2021.170666
10.1021/bi800991e
10.1016/j.ijfoodmicro.2022.110018
10.1074/jbc.M109.081232
10.1038/nprot.2007.521
10.1016/j.drudis.2014.10.003
10.3109/07388551.2011.594423
10.1038/s41598-017-09749-2
10.1007/s00203-021-02474-5
10.1007/s11356-022-19840-5
10.2174/1568026620666200327173815
10.1039/D3RA02473C
10.1021/acsbiomaterials.1c01307
10.3390/ijms23116108
10.3390/molecules27092675
10.3390/antibiotics9110831
10.3390/antibiotics11101338
10.3390/pharmaceutics14050891
10.3390/antibiotics10121465
10.3390/molecules26020430
10.3390/biom12040527
10.3390/antibiotics12020389
10.3390/md20120745
10.3390/microorganisms10050957
10.1128/CMR.00181-19
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
DBID AAYXX
CITATION
3V.
7X7
7XB
88A
88I
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
DOI 10.1007/s10989-024-10632-8
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection‎ (ProQuest)
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
DatabaseTitle CrossRef
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
ProQuest One Academic (New)
DatabaseTitleList ProQuest Central Student

Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1573-3904
ExternalDocumentID 10_1007_s10989_024_10632_8
GrantInformation_xml – fundername: Council of Scientific & Industrial Research
– fundername: Department of Biotechnology, Ministry of Science and Technology, India
  funderid: http://dx.doi.org/10.13039/501100001407
– fundername: Central Drug Research Institute
  funderid: http://dx.doi.org/10.13039/501100004507
GroupedDBID ---
-56
-5G
-BR
-EM
-~C
.86
.VR
06C
06D
0R~
0VY
203
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
4.4
406
408
409
40E
53G
5GY
67N
67Z
6NX
7X7
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHIR
ADINQ
ADKNI
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BENPR
BGNMA
BHPHI
BSONS
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HCIFZ
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HVGLF
I09
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LLZTM
M4Y
M7P
MA-
NB0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
P19
PF0
PT4
PT5
QOR
QOS
R89
R9I
RNS
ROL
RPX
RSV
S16
S27
S3A
S3B
SAP
SBL
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
VC2
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z87
Z8O
Z91
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
3V.
7XB
88A
88I
8AO
8FE
8FH
8FI
8FJ
8FK
ABRTQ
ABUWG
AFKRA
BBNVY
CCPQU
DWQXO
FYUFA
GNUQQ
K9.
LK8
M2P
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-c270t-25814ecf768ced92d681902b5dec4c76b6d0eb39970b9e486574da152210c0fa3
IEDL.DBID U2A
ISSN 1573-3904
1573-3149
IngestDate Tue Sep 02 03:45:40 EDT 2025
Tue Jul 01 02:21:39 EDT 2025
Fri Feb 21 02:41:54 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Toxins
Eskape pathogens
Peptide templates
Host defense peptides
Cell membrane
Scorpion
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c270t-25814ecf768ced92d681902b5dec4c76b6d0eb39970b9e486574da152210c0fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0001-6337-6257
0000-0002-0240-7141
0000-0003-3772-9711
0000-0002-9618-1998
0000-0002-4413-2641
PQID 3103666094
PQPubID 54427
ParticipantIDs proquest_journals_3103666094
crossref_primary_10_1007_s10989_024_10632_8
springer_journals_10_1007_s10989_024_10632_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-09-12
PublicationDateYYYYMMDD 2024-09-12
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-12
  day: 12
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
PublicationSubtitle formerly known as "Letters in Peptide Science"
PublicationTitle International journal of peptide research and therapeutics
PublicationTitleAbbrev Int J Pept Res Ther
PublicationYear 2024
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Zane, Feldman, Sawyer, Sobol, Hawes (CR59) 2021; 40
Das, Bombaywala, Srivastava, Kapley, Dhodapkar, Dafale (CR6) 2022; 29
Fosgerau, Hoffmann (CR13) 2015; 20
Wiegand, Hilpert, Hancock (CR57) 2008; 3
CR35
Svensson, Pasupuleti, Walse, Malmsten, Morgelin, Sjogren, Olin, Collin, Schmidtchen, Palmer, Egesten (CR51) 2010; 285
Greve, Cowan (CR15) 2022; 13
Krishnamoorthy, Adhikari, Anaikutti (CR22) 2023; 13
Park, Kim, Kang, Park (CR34) 2024; 62
Bosso, Di Maro, Cafaro, Di Donato, Notomista, Pizzo (CR3) 2020; 20
Amorim-Carmo, Parente, Souza, Silva-Junior, Araújo, Fernandes-Pedrosa (CR1) 2022; 9
Pizzo, Cafaro, Di Donato, Notomista (CR39) 2018; 24
Rocha, Ferreira (CR43) 2022; 17
CR2
Lata, Telang, Gupta, Pant, Kalyan, Arockiaraj, Pasupuleti (CR23) 2023; 4
Pasupuleti, Chalupka, Morgelin, Schmidtchen, Malmsten (CR36) 2009; 1790
Miyazaki, Shinoda (CR30) 2022; 1864
CR8
Chang, Nang, Chan, Li (CR4) 2022; 187
CR9
CR48
Denissen, Reyneke, Waso-Reyneke, Havenga, Barnard, Khan, Khan (CR10) 2022; 244
CR44
CR42
de Oliveira Costa, Franco (CR7) 2020; 20
Sandhu, Yang, Li (CR46) 2022; 8
Edwards, Elliott, Kavanagh, Zuegg, Blaskovich, Cooper (CR12) 2016; 2
Heselpoth, Euler, Fischetti (CR18) 2022; 13
Pasupuleti, Schmidtchen, Malmsten (CR37) 2012; 32
Malmsten, Davoudi, Walse, Rydengard, Pasupuleti, Morgelin, Schmidtchen (CR28) 2007; 25
Chen, Chen, Yang, Kuo, Jan, Yang, Hsieh, Lee, Lin, Chen (CR5) 2021; 12
Guilhelmelli, Vilela, Smidt, de Oliveira, Álvares da Cunha Morales, Rigonatto, da Silva Costa, Tavares, de Freitas, Nicola, Franco, Derengowski, Schwartz, Mortari, Bocca, Albuquerque, Silva-Pereira (CR16) 2016; 7
Sharma, Bisht (CR50) 2023; 29
CR55
Mueller, Baumruck, Zhdanova, Tietze (CR31) 2020; 8
Matsui, Nakano, Dadashipour, Asano (CR29) 2017; 7
Gondru, Kanugala, Raj, Ganesh Kumar, Pasupuleti, Banothu, Bavantula (CR14) 2021; 33
Raj, Venugopal, Pant, Kalyan, Arockiaraj, Krishnan, Pasupuleti (CR40) 2021; 203
Setty, Horam, Pasupuleti, Haq (CR49) 2017; 23
Pasupuleti, Walse, Svensson, Malmsten, Schmidtchen (CR38) 2008; 47
Horam, Raj, Tripathi, Pant, Kalyan, Reddy, Arockiaraj, Pasupuleti (CR19) 2019; 25
Xia, Song, Zhang, Wang, Zhou, Fan, Li, Dong, Luo, Li, Zhang (CR58) 2023; 386
Ko, Park, Asandei, Choi, Lee, Seo, Luchian, Park (CR21) 2020; 10
Tan, Wang, Xu, Qin, Wang, Cui, Ru (CR52) 2021; 12
Mwangi, Kamau, Thuku, Lai (CR32) 2023; 44
Utterstrom, Barriga, Holme, Selegard, Stevens, Aili (CR54) 2022; 33
CR26
Han, Zhang, Lai, Zhang (CR17) 2021; 146
Wang, Zou, Wen, Liu, Meng, Feng, Zheng, Meng, Wang (CR56) 2021; 27
CR24
Roshanak, Shahidi, Tabatabaei Yazdi, Javadmanesh, Movaffagh (CR45) 2021; 161
CR20
Sarkar, Chetia, Chatterjee (CR47) 2021; 9
Ramesh, Govender, Kruger, de la Torre, Albericio (CR41) 2016; 22
CR60
Maharjan, Khan, Nadeem-Ul-Haque, Maresca, Choudhary, Shaheen, Simjee (CR27) 2022; 14
Papareddy, Rydengård, Pasupuleti, Walse, Mörgelin, Chalupka, Malmsten, Schmidtchen (CR33) 2010; 6
Theansungnoen, Phosri, Bumrungthai, Daduang, Klaynongsruang, Daduang (CR53) 2022; 77
Duan, Zhang, Chen (CR11) 2021; 45
Li, Jing, Yuan, Shui, Li, Zhao, Deng, Zhang (CR25) 2022; 13
R Maharjan (10632_CR27) 2022; 14
F Guilhelmelli (10632_CR16) 2016; 7
S Ramesh (10632_CR41) 2016; 22
S Das (10632_CR6) 2022; 29
E Pizzo (10632_CR39) 2018; 24
Y Han (10632_CR17) 2021; 146
RD Heselpoth (10632_CR18) 2022; 13
X Xia (10632_CR58) 2023; 386
10632_CR26
SJ Ko (10632_CR21) 2020; 10
SL Svensson (10632_CR51) 2010; 285
D Matsui (10632_CR29) 2017; 7
10632_CR24
10632_CR20
SC Setty (10632_CR49) 2017; 23
SP Chen (10632_CR5) 2021; 12
M Lata (10632_CR23) 2023; 4
T Sarkar (10632_CR47) 2021; 9
T Wang (10632_CR56) 2021; 27
10632_CR60
M Pasupuleti (10632_CR37) 2012; 32
GA Rocha (10632_CR43) 2022; 17
10632_CR2
S Horam (10632_CR19) 2019; 25
IA Edwards (10632_CR12) 2016; 2
S Roshanak (10632_CR45) 2021; 161
LK Mueller (10632_CR31) 2020; 8
J Mwangi (10632_CR32) 2023; 44
R Tan (10632_CR52) 2021; 12
10632_CR55
J Park (10632_CR34) 2024; 62
S Raj (10632_CR40) 2021; 203
X Duan (10632_CR11) 2021; 45
P Papareddy (10632_CR33) 2010; 6
I Wiegand (10632_CR57) 2008; 3
R Krishnamoorthy (10632_CR22) 2023; 13
R Gondru (10632_CR14) 2021; 33
10632_CR48
JM Greve (10632_CR15) 2022; 13
AK Sandhu (10632_CR46) 2022; 8
Y Miyazaki (10632_CR30) 2022; 1864
10632_CR44
10632_CR8
10632_CR9
M Malmsten (10632_CR28) 2007; 25
M Pasupuleti (10632_CR38) 2008; 47
J Utterstrom (10632_CR54) 2022; 33
10632_CR42
A Bosso (10632_CR3) 2020; 20
D Zane (10632_CR59) 2021; 40
B Amorim-Carmo (10632_CR1) 2022; 9
Z Li (10632_CR25) 2022; 13
M Pasupuleti (10632_CR36) 2009; 1790
RYK Chang (10632_CR4) 2022; 187
K Fosgerau (10632_CR13) 2015; 20
T Theansungnoen (10632_CR53) 2022; 77
J Denissen (10632_CR10) 2022; 244
10632_CR35
B de Oliveira Costa (10632_CR7) 2020; 20
L Sharma (10632_CR50) 2023; 29
References_xml – volume: 13
  start-page: 862834
  year: 2022
  ident: CR25
  article-title: In vitro and in vivo activity of phibilin against Candida albicans
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2022.862834
– volume: 23
  start-page: 213
  issue: 2
  year: 2017
  end-page: 225
  ident: CR49
  article-title: Modulating the antimicrobial activity of Temporin l through introduction of fluorinated phenylalanine
  publication-title: Int J Pept Res Ther
  doi: 10.1007/s10989-016-9553-5
– volume: 244
  start-page: 114006
  year: 2022
  ident: CR10
  article-title: Prevalence of ESKAPE pathogens in the environment: antibiotic resistance status, community-acquired infection and risk to human health
  publication-title: Int J Hyg Environ Health
  doi: 10.1016/j.ijheh.2022.114006
– volume: 77
  start-page: 1012
  issue: 4
  year: 2022
  end-page: 1019
  ident: CR53
  article-title: Novel non-cytotoxic antimicrobial peptides WSKK11 and WSRR11 with potent activity against Cutibacterium acnes
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkac014
– ident: CR35
– volume: 1790
  start-page: 800
  issue: 8
  year: 2009
  end-page: 808
  ident: CR36
  article-title: Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2009.03.029
– ident: CR8
– volume: 33
  start-page: 736
  issue: 4
  year: 2022
  end-page: 746
  ident: CR54
  article-title: Peptide-folding triggered phase separation and lipid membrane destabilization in cholesterol-rich lipid vesicles
  publication-title: Bioconjug Chem
  doi: 10.1021/acs.bioconjchem.2c00115
– volume: 22
  start-page: 438
  issue: 7
  year: 2016
  end-page: 451
  ident: CR41
  article-title: Short AntiMicrobial peptides (SAMPs) as a class of extraordinary promising therapeutic agents
  publication-title: J Pept Sci
  doi: 10.1002/psc.2894
– ident: CR42
– volume: 33
  start-page: 127746
  year: 2021
  ident: CR14
  article-title: 1,2,3-triazole-thiazole hybrids: synthesis, in vitro antimicrobial activity and antibiofilm studies
  publication-title: Bioorg Med Chem Lett
  doi: 10.1016/j.bmcl.2020.127746
– volume: 9
  start-page: 887763
  year: 2022
  ident: CR1
  article-title: Antimicrobial peptide analogs from scorpions: modifications and structure-activity
  publication-title: Front Mol Biosci
  doi: 10.3389/fmolb.2022.887763
– volume: 25
  start-page: 60
  issue: 1
  year: 2007
  end-page: 70
  ident: CR28
  article-title: Antimicrobial peptides derived from growth factors
  publication-title: Growth Factors
  doi: 10.1080/08977190701344120
– volume: 14
  start-page: 391
  issue: 2
  year: 2022
  end-page: 405
  ident: CR27
  article-title: Serum stable and low hemolytic temporin-sha peptide analogs disrupt cell membrane of methicillin-resistant (MRSA)
  publication-title: Probiotics Antimicrob Proteins
  doi: 10.1007/s12602-022-09915-7
– volume: 13
  start-page: 511
  issue: 5
  year: 2022
  end-page: 521
  ident: CR15
  article-title: Tackling antimicrobial stewardship through synergy and antimicrobial peptides
  publication-title: RSC Med Chem
  doi: 10.1039/D2MD00048B
– volume: 27
  start-page: e3306
  issue: 5
  year: 2021
  ident: CR56
  article-title: The effect of structural modification of antimicrobial peptides on their antimicrobial activity, hemolytic activity, and plasma stability
  publication-title: J Pept Sci
  doi: 10.1002/psc.3306
– volume: 25
  start-page: 1477
  issue: 4
  year: 2019
  end-page: 1489
  ident: CR19
  article-title: Xenobiotic binding domain of glutathione s-transferase has cryptic antimicrobial peptides
  publication-title: Int J Pept Res Ther
  doi: 10.1007/s10989-018-9793-7
– volume: 9
  start-page: 691532
  year: 2021
  ident: CR47
  article-title: Antimicrobial peptides and proteins: from nature’s reservoir to the laboratory and beyond
  publication-title: Front Chem
  doi: 10.3389/fchem.2021.691532
– volume: 12
  start-page: 773076
  year: 2021
  ident: CR52
  article-title: Improving the activity of antimicrobial peptides against aquatic pathogen bacteria by amino acid substitutions and changing the ratio of hydrophobic residues
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2021.773076
– ident: CR9
– volume: 24
  start-page: 1054
  issue: 10
  year: 2018
  end-page: 1066
  ident: CR39
  article-title: Cryptic antimicrobial peptides: identification methods and current knowledge of their immunomodulatory properties
  publication-title: Curr Pharm Des
  doi: 10.2174/1381612824666180327165012
– ident: CR60
– volume: 20
  start-page: 1274
  issue: 14
  year: 2020
  end-page: 1290
  ident: CR7
  article-title: Cryptic host defense peptides: multifaceted activity and prospects for medicinal chemistry
  publication-title: Curr Top Med Chem
  doi: 10.2174/1568026620666200325112425
– volume: 45
  start-page: e13598
  issue: 4
  year: 2021
  ident: CR11
  article-title: Prediction and analysis of antimicrobial peptides from rapeseed protein using in silico approach
  publication-title: J Food Biochem
  doi: 10.1111/jfbc.13598
– volume: 6
  start-page: e1000857
  issue: 4
  year: 2010
  ident: CR33
  article-title: Proteolysis of human thrombin generates novel host defense peptides
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000857
– volume: 187
  start-page: 114378
  year: 2022
  ident: CR4
  article-title: Novel antimicrobial agents for combating antibiotic-resistant bacteria
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2022.114378
– ident: CR26
– volume: 13
  start-page: 817228
  year: 2022
  ident: CR18
  article-title: PaP1, a broad-spectrum lysin-derived cationic peptide to treat polymicrobial skin infections
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2022.817228
– volume: 29
  start-page: e3446
  issue: 1
  year: 2023
  ident: CR50
  article-title: Synergistic effects of short peptides and antibiotics against bacterial and fungal strains
  publication-title: J Pept Sci
  doi: 10.1002/psc.3446
– volume: 8
  start-page: 162
  year: 2020
  ident: CR31
  article-title: Challenges and perspectives in chemical synthesis of highly hydrophobic peptides
  publication-title: Front Bioeng Biotechnol
  doi: 10.3389/fbioe.2020.00162
– volume: 40
  start-page: 108
  issue: 2
  year: 2021
  end-page: 124
  ident: CR59
  article-title: Development and regulatory challenges for peptide therapeutics
  publication-title: Int J Toxicol
  doi: 10.1177/1091581820977846
– volume: 4
  start-page: 100183
  year: 2023
  ident: CR23
  article-title: Evolutionary and in silico guided development of novel peptide analogues for antibacterial activity against ESKAPE pathogens
  publication-title: Curr Res Microb Sci
– volume: 17
  start-page: 701
  year: 2022
  end-page: 716
  ident: CR43
  article-title: Antimicrobial polysaccharides obtained from natural sources
  publication-title: Future Microbiol
  doi: 10.2217/fmb-2021-0257
– volume: 7
  start-page: 1844
  year: 2016
  ident: CR16
  article-title: Activity of Scorpion Venom-derived antifungal peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2016.01844
– volume: 10
  start-page: 10145
  issue: 1
  year: 2020
  ident: CR21
  article-title: Bee venom-derived antimicrobial peptide melectin has broad-spectrum potency, cell selectivity, and salt-resistant properties
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-66995-7
– ident: CR2
– volume: 1864
  start-page: 183955
  issue: 9
  year: 2022
  ident: CR30
  article-title: Cooperative antimicrobial action of melittin on lipid membranes: a coarse-grained molecular dynamics study
  publication-title: Biochim Biophys Acta Biomembr
  doi: 10.1016/j.bbamem.2022.183955
– volume: 2
  start-page: 442
  issue: 6
  year: 2016
  end-page: 450
  ident: CR12
  article-title: Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of beta-hairpin peptides
  publication-title: ACS Infect Dis
  doi: 10.1021/acsinfecdis.6b00045
– volume: 12
  start-page: 678330
  year: 2021
  ident: CR5
  article-title: A systematic study of the stability, safety, and efficacy of the de novo designed antimicrobial peptide pepd2 and its modified derivatives against
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2021.678330
– volume: 161
  start-page: 105301
  issue: Pt B
  year: 2021
  ident: CR45
  article-title: Buforin I an alternative to conventional antibiotics: evaluation of the antimicrobial properties, stability, and safety
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2021.105301
– volume: 44
  start-page: 1095
  issue: 6
  year: 2023
  end-page: 1114
  ident: CR32
  article-title: Design methods for antimicrobial peptides with improved performance
  publication-title: Zool Res
– volume: 62
  start-page: 101
  issue: 2
  year: 2024
  end-page: 112
  ident: CR34
  article-title: Exploring the therapeutic potential of scorpion-derived Css54 peptide against Candida albicans
  publication-title: J Microbiol
  doi: 10.1007/s12275-024-00113-4
– volume: 146
  start-page: 170666
  year: 2021
  ident: CR17
  article-title: Chemical modifications to increase the therapeutic potential of antimicrobial peptides
  publication-title: Peptides
  doi: 10.1016/j.peptides.2021.170666
– volume: 47
  start-page: 9057
  issue: 35
  year: 2008
  end-page: 9070
  ident: CR38
  article-title: Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach
  publication-title: Biochemistry
  doi: 10.1021/bi800991e
– volume: 386
  start-page: 110018
  year: 2023
  ident: CR58
  article-title: The synergy of thanatin and cathelicidin-BF-15a3 combats Escherichia coli O157:H7
  publication-title: Int J Food Microbiol
  doi: 10.1016/j.ijfoodmicro.2022.110018
– ident: CR44
– volume: 285
  start-page: 16105
  issue: 21
  year: 2010
  end-page: 16115
  ident: CR51
  article-title: Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.081232
– ident: CR48
– volume: 3
  start-page: 163
  issue: 2
  year: 2008
  end-page: 175
  ident: CR57
  article-title: Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2007.521
– volume: 20
  start-page: 122
  issue: 1
  year: 2015
  end-page: 128
  ident: CR13
  article-title: Peptide therapeutics: current status and future directions
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2014.10.003
– volume: 32
  start-page: 143
  issue: 2
  year: 2012
  end-page: 171
  ident: CR37
  article-title: Antimicrobial peptides: key components of the innate immune system
  publication-title: Crit Rev Biotechnol
  doi: 10.3109/07388551.2011.594423
– volume: 7
  start-page: 9558
  issue: 1
  year: 2017
  ident: CR29
  article-title: Rational identification of aggregation hotspots based on secondary structure and amino acid hydrophobicity
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-09749-2
– volume: 203
  start-page: 4891
  issue: 8
  year: 2021
  end-page: 4899
  ident: CR40
  article-title: Anti-mycobacterial activity evaluation of designed peptides: cryptic and database filtering based approach
  publication-title: Arch Microbiol
  doi: 10.1007/s00203-021-02474-5
– volume: 29
  start-page: 40507
  issue: 27
  year: 2022
  end-page: 40519
  ident: CR6
  article-title: Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens
  publication-title: Environ Sci Pollut Res Int
  doi: 10.1007/s11356-022-19840-5
– volume: 20
  start-page: 1310
  issue: 14
  year: 2020
  end-page: 1323
  ident: CR3
  article-title: Enzymes as a reservoir of host defence peptides
  publication-title: Curr Top Med Chem
  doi: 10.2174/1568026620666200327173815
– ident: CR55
– volume: 13
  start-page: 15594
  issue: 23
  year: 2023
  end-page: 15605
  ident: CR22
  article-title: Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37
  publication-title: RSC Adv
  doi: 10.1039/D3RA02473C
– volume: 8
  start-page: 1749
  issue: 5
  year: 2022
  end-page: 1762
  ident: CR46
  article-title: antibacterial efficacy of antimicrobial peptides modified metallic implants horizontal line systematic review and meta-analysis
  publication-title: ACS Biomater Sci Eng
  doi: 10.1021/acsbiomaterials.1c01307
– ident: CR24
– ident: CR20
– volume: 1790
  start-page: 800
  issue: 8
  year: 2009
  ident: 10632_CR36
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2009.03.029
– volume: 32
  start-page: 143
  issue: 2
  year: 2012
  ident: 10632_CR37
  publication-title: Crit Rev Biotechnol
  doi: 10.3109/07388551.2011.594423
– volume: 12
  start-page: 773076
  year: 2021
  ident: 10632_CR52
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2021.773076
– volume: 23
  start-page: 213
  issue: 2
  year: 2017
  ident: 10632_CR49
  publication-title: Int J Pept Res Ther
  doi: 10.1007/s10989-016-9553-5
– volume: 1864
  start-page: 183955
  issue: 9
  year: 2022
  ident: 10632_CR30
  publication-title: Biochim Biophys Acta Biomembr
  doi: 10.1016/j.bbamem.2022.183955
– ident: 10632_CR55
  doi: 10.3390/ijms23116108
– volume: 62
  start-page: 101
  issue: 2
  year: 2024
  ident: 10632_CR34
  publication-title: J Microbiol
  doi: 10.1007/s12275-024-00113-4
– volume: 161
  start-page: 105301
  issue: Pt B
  year: 2021
  ident: 10632_CR45
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2021.105301
– volume: 203
  start-page: 4891
  issue: 8
  year: 2021
  ident: 10632_CR40
  publication-title: Arch Microbiol
  doi: 10.1007/s00203-021-02474-5
– volume: 22
  start-page: 438
  issue: 7
  year: 2016
  ident: 10632_CR41
  publication-title: J Pept Sci
  doi: 10.1002/psc.2894
– volume: 13
  start-page: 15594
  issue: 23
  year: 2023
  ident: 10632_CR22
  publication-title: RSC Adv
  doi: 10.1039/D3RA02473C
– ident: 10632_CR24
  doi: 10.3390/molecules27092675
– volume: 25
  start-page: 60
  issue: 1
  year: 2007
  ident: 10632_CR28
  publication-title: Growth Factors
  doi: 10.1080/08977190701344120
– volume: 20
  start-page: 1274
  issue: 14
  year: 2020
  ident: 10632_CR7
  publication-title: Curr Top Med Chem
  doi: 10.2174/1568026620666200325112425
– volume: 13
  start-page: 511
  issue: 5
  year: 2022
  ident: 10632_CR15
  publication-title: RSC Med Chem
  doi: 10.1039/D2MD00048B
– ident: 10632_CR35
  doi: 10.3390/antibiotics9110831
– volume: 244
  start-page: 114006
  year: 2022
  ident: 10632_CR10
  publication-title: Int J Hyg Environ Health
  doi: 10.1016/j.ijheh.2022.114006
– volume: 20
  start-page: 1310
  issue: 14
  year: 2020
  ident: 10632_CR3
  publication-title: Curr Top Med Chem
  doi: 10.2174/1568026620666200327173815
– ident: 10632_CR20
  doi: 10.3390/antibiotics11101338
– volume: 13
  start-page: 862834
  year: 2022
  ident: 10632_CR25
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2022.862834
– volume: 33
  start-page: 127746
  year: 2021
  ident: 10632_CR14
  publication-title: Bioorg Med Chem Lett
  doi: 10.1016/j.bmcl.2020.127746
– volume: 44
  start-page: 1095
  issue: 6
  year: 2023
  ident: 10632_CR32
  publication-title: Zool Res
– ident: 10632_CR44
  doi: 10.3390/pharmaceutics14050891
– volume: 33
  start-page: 736
  issue: 4
  year: 2022
  ident: 10632_CR54
  publication-title: Bioconjug Chem
  doi: 10.1021/acs.bioconjchem.2c00115
– volume: 40
  start-page: 108
  issue: 2
  year: 2021
  ident: 10632_CR59
  publication-title: Int J Toxicol
  doi: 10.1177/1091581820977846
– volume: 6
  start-page: e1000857
  issue: 4
  year: 2010
  ident: 10632_CR33
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000857
– ident: 10632_CR60
  doi: 10.3390/antibiotics10121465
– volume: 45
  start-page: e13598
  issue: 4
  year: 2021
  ident: 10632_CR11
  publication-title: J Food Biochem
  doi: 10.1111/jfbc.13598
– volume: 20
  start-page: 122
  issue: 1
  year: 2015
  ident: 10632_CR13
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2014.10.003
– volume: 29
  start-page: e3446
  issue: 1
  year: 2023
  ident: 10632_CR50
  publication-title: J Pept Sci
  doi: 10.1002/psc.3446
– volume: 12
  start-page: 678330
  year: 2021
  ident: 10632_CR5
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2021.678330
– volume: 3
  start-page: 163
  issue: 2
  year: 2008
  ident: 10632_CR57
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2007.521
– volume: 8
  start-page: 1749
  issue: 5
  year: 2022
  ident: 10632_CR46
  publication-title: ACS Biomater Sci Eng
  doi: 10.1021/acsbiomaterials.1c01307
– ident: 10632_CR2
  doi: 10.3390/molecules26020430
– volume: 9
  start-page: 691532
  year: 2021
  ident: 10632_CR47
  publication-title: Front Chem
  doi: 10.3389/fchem.2021.691532
– volume: 2
  start-page: 442
  issue: 6
  year: 2016
  ident: 10632_CR12
  publication-title: ACS Infect Dis
  doi: 10.1021/acsinfecdis.6b00045
– ident: 10632_CR26
  doi: 10.3390/biom12040527
– volume: 187
  start-page: 114378
  year: 2022
  ident: 10632_CR4
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2022.114378
– ident: 10632_CR42
  doi: 10.3390/antibiotics12020389
– volume: 29
  start-page: 40507
  issue: 27
  year: 2022
  ident: 10632_CR6
  publication-title: Environ Sci Pollut Res Int
  doi: 10.1007/s11356-022-19840-5
– volume: 47
  start-page: 9057
  issue: 35
  year: 2008
  ident: 10632_CR38
  publication-title: Biochemistry
  doi: 10.1021/bi800991e
– volume: 146
  start-page: 170666
  year: 2021
  ident: 10632_CR17
  publication-title: Peptides
  doi: 10.1016/j.peptides.2021.170666
– volume: 27
  start-page: e3306
  issue: 5
  year: 2021
  ident: 10632_CR56
  publication-title: J Pept Sci
  doi: 10.1002/psc.3306
– ident: 10632_CR9
  doi: 10.3390/md20120745
– ident: 10632_CR48
  doi: 10.3390/microorganisms10050957
– volume: 14
  start-page: 391
  issue: 2
  year: 2022
  ident: 10632_CR27
  publication-title: Probiotics Antimicrob Proteins
  doi: 10.1007/s12602-022-09915-7
– volume: 7
  start-page: 9558
  issue: 1
  year: 2017
  ident: 10632_CR29
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-09749-2
– ident: 10632_CR8
  doi: 10.1128/CMR.00181-19
– volume: 77
  start-page: 1012
  issue: 4
  year: 2022
  ident: 10632_CR53
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkac014
– volume: 285
  start-page: 16105
  issue: 21
  year: 2010
  ident: 10632_CR51
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.081232
– volume: 25
  start-page: 1477
  issue: 4
  year: 2019
  ident: 10632_CR19
  publication-title: Int J Pept Res Ther
  doi: 10.1007/s10989-018-9793-7
– volume: 17
  start-page: 701
  year: 2022
  ident: 10632_CR43
  publication-title: Future Microbiol
  doi: 10.2217/fmb-2021-0257
– volume: 7
  start-page: 1844
  year: 2016
  ident: 10632_CR16
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2016.01844
– volume: 24
  start-page: 1054
  issue: 10
  year: 2018
  ident: 10632_CR39
  publication-title: Curr Pharm Des
  doi: 10.2174/1381612824666180327165012
– volume: 386
  start-page: 110018
  year: 2023
  ident: 10632_CR58
  publication-title: Int J Food Microbiol
  doi: 10.1016/j.ijfoodmicro.2022.110018
– volume: 10
  start-page: 10145
  issue: 1
  year: 2020
  ident: 10632_CR21
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-66995-7
– volume: 4
  start-page: 100183
  year: 2023
  ident: 10632_CR23
  publication-title: Curr Res Microb Sci
– volume: 8
  start-page: 162
  year: 2020
  ident: 10632_CR31
  publication-title: Front Bioeng Biotechnol
  doi: 10.3389/fbioe.2020.00162
– volume: 9
  start-page: 887763
  year: 2022
  ident: 10632_CR1
  publication-title: Front Mol Biosci
  doi: 10.3389/fmolb.2022.887763
– volume: 13
  start-page: 817228
  year: 2022
  ident: 10632_CR18
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2022.817228
SSID ssj0052710
Score 2.3495283
Snippet Background The emergence of multidrug-resistant pathogens through excessive and indiscriminate use of antibiotics, together with the lack of highly efficient...
BackgroundThe emergence of multidrug-resistant pathogens through excessive and indiscriminate use of antibiotics, together with the lack of highly efficient...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 57
SubjectTerms Amino acids
Animal Anatomy
Antibiotic resistance
Antibiotics
Antimicrobial activity
Antimicrobial agents
Antimicrobial peptides
Biochemistry
Biomedical and Life Sciences
Cytotoxicity
Histology
Hydrophobicity
Life Sciences
Molecular Medicine
Morphology
Multidrug resistance
Pathogens
Peptide synthesis
Peptides
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Polymer Sciences
Random coil
Structure-function relationships
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ1Pb9MwFMAtKAe4INYyrdBN74C4bNFSJ7HrE8oqpgqJUamt6C1K_JwtEk1KEw79Anxunt2EDiQ4WpF9yHt-_j37_WHsnUKpjeDooa_RoxMPvVRI4UmeowojhUbZfOfPd2K2Cj-to3V74Va3YZWdTXSGGitt78ivbT8sQm3yRj5sv3u2a5R9XW1baDxlz2zpMhvSJde_Ha6Iy0M1gkjaHLJQtUkzbeqcCxbiIRkiEZBV-PNgOtLmXw-k7ty5fcVetsAI8UHCJ-yJKftsEJfkLG_28B5cCKe7G--z59OufduA_VzsS4I7mgWLB2JsmO72WzuKy6bYFK7-Eq07t1EtaGpIa1iazfabZU8gkgWaDI9CiqDK4a6iIdwUj7O2aojv04IgE77OvsB8V1S2HR7MiSwrUs7XbHX7cTmdeW3TBU9z6Tcejybj0Oic3BBtUHEUlhl4FqHRoZYiE-iTA66U9DNlwomIZIgpUQD5jtrP0-CU9cqqNGcMghQJjpSZIFFOmueZcK_c0gR5pMdjHLLL7o8n20NtjeRYRdnKJyH5JE4-yWTIRp1Qknaf1clRK4bsqhPU8fO_V3vz_9Xeshfc6obrFTFivWb3w5wTfTTZhVOxX2eP154
  priority: 102
  providerName: ProQuest
Title Synthetic Short Cryptic Antimicrobial Peptides as Templates for the Development of Novel Biotherapeutics Against WHO Priority Pathogen
URI https://link.springer.com/article/10.1007/s10989-024-10632-8
https://www.proquest.com/docview/3103666094
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9tAEB3xcYBL1UIRKTSaA-JCLTkbezd7NFFoVESIgKjhZNm7a2qpsaM4HPIH-rs7u9hKiuDQk7Xyzh48szPveWd2AM6kFspwpj3tK-1RxNNewgX3BMu0DEKpjbT1zjcjPpwEP6bhtC4Kq5ps9-ZI0nnqjWI3l97DAnIdvEv7eBt2Q8vdyYonLGr8b8goaNblMW_L_RuC1rjy1VGoizBXH-FDDQ0xetHlJ9gyxQEcRgXR4tkKz9Ela7q_4Aew128atR3Cn_tVQTCOpPD-F6Fp7C9WczuKimU-y91NS7Tu2OavaFNhUuGDmc1_W5SJhFmRhHEjeQjLDEclDfEy36zPqjB6SnKCk_hzeIvjRV7axnc4JgxZkhl-hsnV4KE_9Or2Cp5iwl96LOx1AqMyIhzKaMk0t-iApaE2KlCCp1z7RLWlFH4qTdDjoQh0QvGeWKLys6R7BDtFWZhjwG6iCQZJ09OEZ5IsS7k7zxamm4Wq09EtuGi-eDx_uUUjXt-XbPUTk35ip5-414LTRilxvaOq2PZDI6pFbLQF3xpFrV-_v9qX_5t-AvvM2orrEnEKO8vFs_lKuGOZtmFbTEUbdqPvj9cDel4ORuO7tjO-v95j1tU
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Rb9MwED6N7mG8INhAFAbcA_ACEanj2PUDQl3Z1LGtVKwTewuJ7UAkmpSmCPUP8HP4jZzdRB1I8LZHK_I95M5339l39wE8VUZqK5gJTKhNQBHPBKmQIpAsN4rHyljl-p3PxmJ0wd9dxpdb8KvthXFlla1P9I7aVNrdkb9yfFgEtSkbeTP_FjjWKPe62lJorM3ixK5-UMpWvz5-S_p9xtjR4XQ4ChpWgUAzGS4DFvd73OqccLa2RjEjXFBkWWys5lqKTJiQMkylZJgpy_siltykFOYoOdJhnkYk9wZs84hSmQ5sHxyOJx9a3x8zuZ5_EEvXtcZV06bTNOv58iTGyfWJiPzQn6Fwg2__epL1ke7oNtxqICoO1jZ1B7ZsuQt7g5LS89kKn6MvGvW38buwM2wJ4_bg5_mqJDhJu_D8C6F6HC5Wc7calMtiVviJTyR34upojK0xrXFqZ_OvDu0iYWekzXiliAmrHMcVLfGguNonVuPgc1oQrMWPo_c4WRSVI-DDCWHZio7DXbi4FoXcg05ZlfY-YJQagmPK9g3hqjTPM-Hf1aWN8lj3eqYLL9o_nszX0zySzdxmp5-E9JN4_ST9Luy3Skmak10nGzvswstWUZvP_5b24P_SnsDOaHp2mpwej08ewk3m7MQzVexDZ7n4bh8R9llmjxuDQ_h03Tb-GzOTFV4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NIQEvCDYQHQPuAXiBaKkT2_UDQqWj6hiUSttE37LEdiDSmpSmCPUL8KH4dJzdhA4keNujFfkecj_f_c6-PwBPlZHaCmYCE2oTkMczQSqkCCTLjYq5Mla5eucPYzE6i99N-XQLfra1MC6tsrWJ3lCbSrs78gM3D4uoNkUjB3mTFjE5HL6efw3cBCn30tqO01hD5NiuvlP4Vr86OiRdP2Ns-PZ0MAqaCQOBZjJcBoz3urHVOXFubY1iRjgHyTJurI61FJkwIUWbSskwUzbuCS5jk5LLo0BJh3kakdxrcF1GvOvOmJz-DvY4k-tOCFy6-rVYNQU7TdmeT1RiMRlBEZFF-tMpbpjuX4-z3ucN78Dthqxif42uu7Blyx3Y7ZcUqM9W-Bx9-qi_l9-Bm4N2dNwu_DhZlUQsaReefCF-j4PFau5W_XJZzArf-4nkTlxGjbE1pjWe2tn8wvFeJBaNtBkvpTNhleO4oiW-KS5XjNXY_5wWRHDx0-gjThZF5Ubx4YRYbUUH4x6cXYk67sN2WZX2AWCUGiJmyvYMMaw0zzPhX9iljXKuu13TgRftH0_m674eyaaDs9NPQvpJvH6SXgf2W6UkzRmvkw0iO_CyVdTm87-l7f1f2hO4QchO3h-Njx_CLeZg4kdW7MP2cvHNPiIStMwee7QhnF81vH8BN3EYLg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthetic+Short+Cryptic+Antimicrobial+Peptides+as+Templates+for+the+Development+of+Novel+Biotherapeutics+Against+WHO+Priority+Pathogen&rft.jtitle=International+journal+of+peptide+research+and+therapeutics&rft.au=Lata%2C+Manjul&rft.au=Telang%2C+Vrushti&rft.au=Gupta%2C+Pooja&rft.au=Pant%2C+Garima&rft.date=2024-09-12&rft.issn=1573-3904&rft.eissn=1573-3904&rft.volume=30&rft.issue=5&rft_id=info:doi/10.1007%2Fs10989-024-10632-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10989_024_10632_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1573-3904&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1573-3904&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1573-3904&client=summon